Tokyo Tape
Sign in
← Sumitomo Chemical

Quarterly report · Q2

4005.TEDINET S100PHEX
Period2022-04-01 → 2022-09-30
Filed2022-11-08
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 59
MetricValuePeriodScopeSource row
Revenue¥1.53T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥754.4bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥2.77T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.33T2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥686.2bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥60.6bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥5.7bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥144.3bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥85.9bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥126.8bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥13.1bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥251.1bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥146.8bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥90.1bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥81.1bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥11.1bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥162.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥88.9bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥53.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥73.1bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥12.0bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥186.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥107.8bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥68.9bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥4.68Tat 2022-09-30Cons.Assets IFRS
Total assets¥4.31Tat 2022-03-31Cons.Assets IFRS
Total assets¥4.08Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.79Tat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥2.61Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.89Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥1.70Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.55Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥1.48Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.38Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.22Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.08Tat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥486.0bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥365.4bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥346.8bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥360.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥83.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥171.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥77.2bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥15.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥115.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥65.2bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥24.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥81.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥27.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥49.582022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥6.772022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥99.162021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥54.362021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.552021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥49.572022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥6.772022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio29.5%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.3%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.5%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 124
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥79.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-07-01 → 2022-09-30¥47.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥37.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-07-01 → 2022-09-30¥23.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥42.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-07-01 → 2022-09-30¥24.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-07-01 → 2022-09-30−¥708m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥57.6bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥32.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥57.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥32.7bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥11.6bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥4.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2022-04-01 → 2022-09-30¥183.7bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2022-07-01 → 2022-09-30¥92.4bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-09-30¥173.5bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2022-07-01 → 2022-09-30¥87.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥10.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥5.3bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-09-30¥13.4bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2022-07-01 → 2022-09-30¥6.8bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2022-04-01 → 2022-09-30¥470.4bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2022-07-01 → 2022-09-30¥230.3bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2022-04-01 → 2022-09-30¥467.3bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2022-07-01 → 2022-09-30¥228.7bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥3.1bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥1.6bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2022-04-01 → 2022-09-30¥23.3bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2022-07-01 → 2022-09-30¥13.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥295.9bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2022-07-01 → 2022-09-30¥142.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥293.9bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2022-07-01 → 2022-09-30¥141.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥36.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2022-07-01 → 2022-09-30¥14.4bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2022-04-01 → 2022-09-30¥222.4bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2022-07-01 → 2022-09-30¥107.7bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2022-04-01 → 2022-09-30¥222.2bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2022-07-01 → 2022-09-30¥107.5bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥234m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥118m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2022-04-01 → 2022-09-30¥26.4bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2022-07-01 → 2022-09-30¥10.7bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥334.5bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2022-07-01 → 2022-09-30¥166.7bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥334.4bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2022-07-01 → 2022-09-30¥166.7bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥7m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥1m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥25.2bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2022-07-01 → 2022-09-30¥11.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥1.51T
—segment totalrevenue2022-07-01 → 2022-09-30¥739.5bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.49T
—segment totalrevenue external2022-07-01 → 2022-09-30¥731.4bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥15.5bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥8.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥124.7bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥56.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥59.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-07-01 → 2021-09-30¥31.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥30.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-07-01 → 2021-09-30¥17.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥29.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-07-01 → 2021-09-30¥14.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥6.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-07-01 → 2021-09-30¥4.0bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥41.3bn
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥20.3bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥41.3bn
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥20.3bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥10.4bn
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥5.4bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2021-04-01 → 2021-09-30¥154.5bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2021-07-01 → 2021-09-30¥77.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2021-04-01 → 2021-09-30¥148.5bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2021-07-01 → 2021-09-30¥74.1bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥6.0bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥3.0bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2021-04-01 → 2021-09-30¥12.6bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2021-07-01 → 2021-09-30¥5.9bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2021-04-01 → 2021-09-30¥402.1bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2021-07-01 → 2021-09-30¥201.4bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2021-04-01 → 2021-09-30¥399.5bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2021-07-01 → 2021-09-30¥200.0bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥2.6bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥1.4bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2021-04-01 → 2021-09-30¥42.0bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2021-07-01 → 2021-09-30¥18.2bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥212.8bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2021-07-01 → 2021-09-30¥107.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥209.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2021-07-01 → 2021-09-30¥106.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥955m
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30¥18.5bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2021-07-01 → 2021-09-30¥8.2bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2021-04-01 → 2021-09-30¥227.9bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2021-07-01 → 2021-09-30¥118.5bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2021-04-01 → 2021-09-30¥227.7bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2021-07-01 → 2021-09-30¥118.4bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥226m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥116m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2021-04-01 → 2021-09-30¥29.5bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2021-07-01 → 2021-09-30¥16.0bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥309.6bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2021-07-01 → 2021-09-30¥170.4bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥309.6bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2021-07-01 → 2021-09-30¥170.4bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥9m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥7m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥50.0bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2021-07-01 → 2021-09-30¥40.3bn
—segment totalrevenue2021-04-01 → 2021-09-30¥1.31T
—segment totalrevenue2021-07-01 → 2021-09-30¥674.7bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥1.29T
—segment totalrevenue external2021-07-01 → 2021-09-30¥669.2bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥12.2bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥5.5bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥152.6bn
—segment totalsegment profit2021-07-01 → 2021-09-30¥88.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 994
ItemContextValueUnit
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember934438000000JPY
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-8339000000JPY
Equity IFRSPrior1QuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember65146000000JPY
Equity IFRSPrior1QuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-2866000000JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-31279000000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember56445000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember1019230000000JPY
Equity IFRSPrior2YearInstant_NonControllingInterestsIFRSMember462889000000JPY
Equity IFRSPrior2YearInstant1482119000000JPY
Profit loss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember88884000000JPY
Profit loss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember18926000000JPY
Profit loss IFRSPrior1YTDDuration107810000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-2427000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember10013000000JPY
Other comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-12127000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-12127000000JPY
Other comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-13366000000JPY
Other comprehensive income IFRSPrior1YTDDuration-25493000000JPY
Comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-2427000000JPY
Comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember10013000000JPY
Comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-12127000000JPY
Comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember76757000000JPY
Comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember5560000000JPY
Comprehensive income IFRSPrior1YTDDuration82317000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-5000000JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration-5000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration－JPY
Dividends ss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-14715000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass